Valirx Share Discussion Threads

[nico115] 07/10/2020 15:20

Volume drying up I'm still at 130pMkt cap 14m for all our drugs is crazy Great 201 results Mkt cap of 60m is fair

[bobaxe1] 07/10/2020 14:41

Going blue

[bobaxe1] 07/10/2020 14:12

True can't trust the viper's tongue

[412069] 07/10/2020 13:59

He’s never going to get them at 6p tho ever again.
Think he’s lucky buying around this share price to be honest. Hey ho come the day he puts a ramp on here.... will be funny.

[nico115] 07/10/2020 13:52

Oh but you are You derampTo buy Very clever

[johnsmith777] 07/10/2020 13:41

I'm 100% not a buyer simples

[johnsmith777] 07/10/2020 13:40

Red still red

[bobaxe1] 07/10/2020 12:58

Off topic distraction, more money to be made here as were well oversold

[53tom] 07/10/2020 12:07

Nuformix boosts coffers to support ambitious growth plans; looks to target COVID-19 indications for its assets
"The board is positive about the opportunities for the group, in particular, for the development of certain assets for the treatment of Covid-19. Support for these efforts will require additional business development resource”

Nuformix PLC (LON:NFX) said it is raising £650,000 as it looks to develop its assets to help fight coronavirus (COVID-19).
The drug re-purposing specialist is placing 23.2mln shares at 2.8p each with existing and new investors.
The cash injection will help strengthen data packages around drugs it has identified for treating the effects of coronavirus.
It will also be used to “maximise opportunities” for development pipeline - especially its lead asset, NXP002. The drug is being developed to tackle idiopathic pulmonary fibrosis, but Nuformix believes there is the potential to use it treat the worst symptoms of COVID-19. It also thinks it could be used as combination therapy alongside other existing IPF treatments.
The proceeds from the fundraiser will also be used to recruit a chief executive “with responsibility for delivering the group's strategy and to “augment and strengthen the board” with additional non-executive expertise.
In a progress report, the company said it is expanding its business development strategy to “optimise chances of securing additional deals and drive maximum value for shareholders”.
And it has accelerated its licensing activities for the lead asset, NXP002, to identify global partners in addition to the ongoing negotiations in Asia.
Finally, Nuformix said it wants to “exploit value” from NXP001 in indications outside the field of oncology.
In a statement, it added: “The board is positive about the opportunities for the group, in particular, for the development of certain assets for the treatment of Covid-19. Support for these efforts will require additional business development resource.”

[nico115] 07/10/2020 12:00

Derampers are buyers Period

[wulber] 07/10/2020 11:11

Blue!What sort of posts are these? Waste of time and filtered.

[412069] 07/10/2020 11:05

If you had to put your balls on the block before you make these statements I very much doubt you would.

[rapidlyprogressing] 07/10/2020 08:47

10% red minimum today

[jusjusjus] 07/10/2020 08:21

many still in profit @25p, without news (can't see anything in the near future, no more from 201 until full results available in December) they will continue to sell

waiting for a re-entry point...

[rapidlyprogressing] 07/10/2020 08:17

Down she goes

[jungmana] 07/10/2020 08:00

From the experts;Professor Alan Boyd, Consultant Pharmaceutical Physician and Medical Monitor for the study commented: "Development of effective treatments with low-side effects for patients with prostate cancer who have relapsed after radiotherapy is essential and will improve the lives of patients during treatment. I am pleased to have contributed to a project that has demonstrated such a good safety and tolerability profile while giving the first indications of a favourable effect

[nico115] 07/10/2020 07:43

Listen to the BRR podcast Do we listen to the CEO Suzy Dilly who said quite simply "it works" when discussing 201 Or do we listen to John who has been Uber bearish since 7p and is bitter with the old mgmnt For me it's a no brainer Suzy is an excellent CEO and our mkt cao makes us one of the cheapest and most exciting companies on AIMAny deramping is only because they're as to buy your shares !! They are not deramping because they are bearish at mkt cap of 15m !!

[412069] 07/10/2020 07:28

3p or 30p today JS ?

[johnsmith777] 07/10/2020 07:01

No side effects? Have you seen the results?

[the stigologist] 07/10/2020 02:43

LOL cretin